Skip to main content

Atrial Fibrillation

  • Chapter
  • First Online:
Drug Therapy for the Elderly
  • 1884 Accesses

Abstract

Atrial fibrillation (AF) is a very common and relevant disease of the elderly (Fig. 1). Of the general population, 1%, but 10% of the 80+-year-old age group, suffer from it. In the United States alone, 2.2 million patients have AF, with an unknown number of undiagnosed cases (which may represent another two million patients), and this figure is expected to at least double by 2050. In Europe, the number of AF patients is estimated to be around six million.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  • Alikhan R, Cohen AT, Combe S et al (2003) Prevention of venous thromboembolism in medical patients with enoxaparin: a subgroup analysis of the MEDENOX study. Blood Coagul Fibrinolysis 14:341–346

    Article  PubMed  CAS  Google Scholar 

  • Fuster V, Ryden LE, Cannom DS et al (2006) ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to revise the 2001 guidelines for the management of patients with atrial fibrillation): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation 114:e257–e354

    Article  PubMed  Google Scholar 

  • Fuster V, Rydén LE, Cannom DS et al (2011) 2011 ACCF/AHA/HRS focused updates incorporated into the ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation: a report of the American College of Cardiology Foundation/American Heart Association Task Force on practice guidelines. Circulation 123:e269–e367

    Article  PubMed  Google Scholar 

  • Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition). Chest 133(6 suppl):381S–453S

    Article  PubMed  CAS  Google Scholar 

  • Harenberg J, Bauersachs R, Diehm, C et al (2010) Antikoagulation im Alter [Anticoagulation in the elderly] Internist (Berl) 51:1446–1455, in German

    Google Scholar 

  • Hohnloser SH, Crijns HJ, van Eickels M et al (2009) Effect of dronedarone on cardiovascular events in atrial fibrillation. N Engl J Med 360:668–678

    Article  PubMed  CAS  Google Scholar 

  • Nieuwlaat R, Capucci A, Lip GY, Euro Heart Survey Investigators et al (2006) Antithrombotic treatment in real-life atrial fibrillation patients: a report from the Euro Heart Survey on atrial fibrillation. Eur Heart J 27:3018–3026

    Article  PubMed  CAS  Google Scholar 

  • Rossol-Haseroth K, Vogel CU, Reinecke F et al (2002) Empfehlungen zur Thromboembolieprophylaxe bei internistischen Patienten im Alter. Internist (Berl) 43:1134–1147

    Article  CAS  Google Scholar 

  • Roy D, Talajic M, Nattel S et al (2008) Atrial fibrillation and congestive heart failure investigators. Rhythm control versus rate control for atrial fibrillation and heart failure. N Engl J Med 358:2667–2677

    Article  PubMed  CAS  Google Scholar 

  • Savelieva I, Camm AJ (2001) Clinical trends in atrial fibrillation at the turn of the millennium. J Intern Med 250:369–372

    Article  PubMed  CAS  Google Scholar 

  • Spyropoulos AC, Merli G (2006) Management of venous thromboembolism in the elderly. Drugs Aging 23:651–671

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Martin Wehling .

Editor information

Editors and Affiliations

Study Acronyms

AFASAK

Copenhagen Atrial Fibrillation, Aspirin, Anticoagulation Study

AF-CHF

Atrial Fibrillation and Congestive Heart Failure

AFFIRM

Atrial Fibrillation Follow-up Investigation of Rhythm Management

ARISTOTLE

Apixaban for the Prevention of Stroke in Subjects with Atrial Fibrillation

ATHENA

A Placebo-Controlled, Double-Blind, Parallel Arm Trial to Assess the Efficacy of Dronedarone 400 mg bid for the Prevention of Cardiovascular Hospitalization or Death from Any Cause in Patients with Atrial Fibrillation/Atrial Flutter

BAATAF

Boston Area Anticoagulation Trial for Atrial Fibrillation

CAFA

Canadian Atrial Fibrillation Anticoagulation Study

EAFT

European Atrial Fibrillation Trial

MEDENOX

Prophylaxis in Medical Patients with Enoxaparin Study

PALLAS

Permanent Atrial Fibrillation Outcome Study Using Dronedarone on Top of Standard Therapy

RACE Studie

Rate Control Versus Electrical Cardioversion of Persistent Atrial Fibrillation Study

RE-LY

Randomized Evaluation of Long Term Anticoagulant Therapy

ROCKET AF

Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation

SPAF Studie

Stroke Prevention in Atrial Fibrillation Study

SPINAF Studie

Stroke Prevention in Nonrheumatic Atrial Fibrillation Study

Rights and permissions

Reprints and permissions

Copyright information

© 2013 Springer-Verlag Wien

About this chapter

Cite this chapter

Wehling, M. (2013). Atrial Fibrillation. In: Wehling, M. (eds) Drug Therapy for the Elderly. Springer, Vienna. https://doi.org/10.1007/978-3-7091-0912-0_9

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-0912-0_9

  • Published:

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-7091-0911-3

  • Online ISBN: 978-3-7091-0912-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics